Sensus Healthcare Inc (SRTS)
5.84
+0.09
(+1.57%)
USD |
NASDAQ |
Sep 27, 16:00
5.84
0.00 (0.00%)
After-Hours: 18:57
Sensus Healthcare Research and Development Expense (Annual): 3.678M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 3.678M |
| December 31, 2022 | 3.46M |
| December 31, 2021 | 3.436M |
| December 31, 2020 | 4.158M |
| December 31, 2019 | 6.418M |
| December 31, 2018 | 6.260M |
| Date | Value |
|---|---|
| December 31, 2017 | 5.490M |
| December 31, 2016 | 1.824M |
| December 31, 2015 | 1.467M |
| December 31, 2014 | 1.577M |
| December 31, 2013 | 1.333M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
3.436M
Minimum
2021
6.418M
Maximum
2019
4.230M
Average
3.678M
Median
2023
Research and Development Expense (Annual) Benchmarks
| Perspective Therapeutics Inc | 21.31M |
| Retractable Technologies Inc | 0.5812M |
| InfuSystems Holdings Inc | -- |
| Xtant Medical Holdings Inc | 1.336M |
| Catheter Precision Inc | 0.475M |